IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crispr Therapeutics AG (CRSP)

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
AlphaCore Capital LLC
NEW
Shares167
Change+167
Value$82.0K
Filed 2026-11-04
Status
AlphaCore Capital LLC
NEW167—+167——$82.0K—2026-11-04
Showing 1 of 1 institutions